Effect of Vitamin D on Metabolic Profile in Overweight or Obese Women

NCT01344161 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2012-10-11

Study results available
· View outcomes & findings →

Summary

The investigators investigated the effect of vitamin D3 supplementation on metabolic profile (anthropometric measures, blood pressure Lipids, lipoproteins and glycemic indices) in overweight or obese women.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

dosage form:lactose dosage: 25 micrograms frequency: every day duration: 12weeks

DIETARY_SUPPLEMENT

vitamin D

dosage form:cholecalciferol dosage: 25 micrograms (1000 International Unit) frequency: every day duration: 12weeks

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    collaborator OTHER
  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Farzad Shidfar, PhD · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-02-28
Completion
2010-03-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344161 on ClinicalTrials.gov